drugset / Trial / NCT00004801
Phase I/II Study of Monoclonal Factor IX Concentrate for Factor IX Deficiency
Phase 1/2
Completed
3 enrolled
National Center for Research Resources (NCRR)
University of North Carolina · collab
Treatment
Summary
OBJECTIVES: Assess the safety and long-term efficacy of monoclonal factor IX concentrate in patients with factor IX deficiency.
Timeline
- Start
- 1992-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | monoclonal factor IX concentrate | Unknown | — | — |